European Pharmaceutical Review

FEBRUARY 14, 2023

The COVID-19 pandemic led to an unparalleled paradigm shift in the use of and the incorporation of new technologies into our workflows. This was particularly apparent in academia and the pharmaceutical industry, where we have seen words such as Teams and Zoom becoming part of our new lexicon of language for meetings. Now we reach for these types of online meetings without a second thought, due to the clear productivity benefits they provide over real in-person meetings. 1 However, notwithstandin

129

129

Pharmafile

FEBRUARY 13, 2023

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, from the US market. The drug is used for treating high blood pressure, angina and some types of irregular heartbeat. This recall follows the FDA’s Enforcement Report, which saw “failed impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

FDA 115

FDA Communication 115

PhRMA

FEBRUARY 16, 2023

Did you know that insurance companies use middlemen — known as pharmacy benefit managers (PBMs) — to decide what medicines people can get and what people pay out of pocket for those medicines?

Insurance 298

Insurance 298

Drug Topics

FEBRUARY 1, 2023

Geographical data could potentially yield insight on racial and ethnic health disparities in the United States. An analysis of the large dataset could help identify any potential causes for observed inequities.

234

234

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 17, 2023

One day last fall, Kiran’s period cramps became so painful they woke her up from a nap. The 19-year-old took some ibuprofen, but found little relief. “The pain was so bad, it felt like someone was punching me,” said Kiran, who asked to be referred to by only her first name for privacy. It felt “like I was giving birth.

145

145

Fierce Pharma

FEBRUARY 3, 2023

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries mbayer Fri, 02/03/2023 - 09:29

145

145

Fierce Healthcare

FEBRUARY 11, 2023

Doximity rolls out beta version of ChatGPT tool for docs aiming to streamline administrative paperwork hlandi Sat, 02/11/2023 - 05:02

145

145

PhRMA

FEBRUARY 23, 2023

State legislative sessions across the country are in full swing, and many state officials have made lowering the cost of medicine for patients a top priority. If policymakers are serious about addressing high out-of-pocket costs for patients, they should start by taking steps to finally hold pharmacy benefit managers (PBMs) accountable.

Insurance 277

Insurance 277

Drug Topics

FEBRUARY 15, 2023

Viruses are known to precipitate autoimmune diseases, but the link between COVID-19 and autoimmune conditions requires additional research.

266

266

STAT

FEBRUARY 15, 2023

In an unexpected shift, Moderna has decided not to ask Americans to pay for its Covid-19 vaccine, a move that follows intense criticism over initial plans to charge $110 to $130 per dose after the company pivots from government contracts to commercial distribution. The vaccine maker released a brief statement that it “remains committed” to ensuring everyone in the U.S. has access to its Covid-19 shot, regardless of whether they have health insurance coverage.

Vaccines 145

Vaccines Insurance Coverage Insurance 145

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

FEBRUARY 24, 2023

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18

Vaccines 145

Vaccines 145

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabin

Pharmaceutical Companies 129

Pharmaceutical Companies Pharmaceutical Companies Compounding 129

The Checkup by Singlecare

FEBRUARY 13, 2023

Lots of people love the idea of taking something natural to improve their health. For example, the idea of taking a supplement that could improve their blood pressure and reduce their chances of heart attack or cardiovascular disease may be very appealing. But how effective–and safe–is this strategy? Before you decide to start taking any supplements for their alleged antihypertensive effects, it’s important to understand what those supplements can and can’t do.

Mayo Clinic 119

Mayo Clinic Labelling FDA 119

PhRMA

FEBRUARY 28, 2023

For over a decade, Rare Disease Day has been celebrated on February 28 to raise awareness and generate change for the more than 30 million patients in the U.S. living with a rare disease. This year’s Rare Disease Day is particularly special because this year also marks the 40 th anniversary of the Orphan Drug Act (ODA), allowing us to celebrate all the progress that’s come to patients because of it.

271

271

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Topics

FEBRUARY 6, 2023

Artificial intelligence has the potential to revolutionize and improve medicine. However, in order for widespread implementation, certain challenges and obstacles must first be overcome.

201

201

STAT

FEBRUARY 16, 2023

Matt Fitzgerald used to bike up and down 3,500 feet through the Santa Ana Mountains on three-hour rides just for fun. Now, nine months after being infected with SARS-CoV-2, the virus that causes Covid-19, he can’t muster walking on flat surfaces for 20 minutes without days of exhaustion. “My long Covid life remains terrifying,” he told me.

144

144

Pharmafile

FEBRUARY 8, 2023

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure for the common cold from algae. The Livingston-based company is assessing how waste molecules from spirulina, an algae often consumed as a superfood, could be used as a cure for the common cold, COVID-19 and various other viruses.

Communication 117

Communication 117

Pharmaceutical Technology

FEBRUARY 3, 2023

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections. This marks the second time one of Janssen’s HIV vaccines failed after another showed disappointing results in the Phase IIb Imbokodo trial in August 2021.

Vaccines 117

Vaccines Immunization 117

Fierce Pharma

FEBRUARY 15, 2023

GSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg esagonowsky Wed, 02/15/2023 - 09:02

140

140

Fierce Healthcare

FEBRUARY 16, 2023

Senators question why PBMs 'even exist' in heated hearing amid push for reform rking Thu, 02/16/2023 - 14:49

144

144

Drug Topics

FEBRUARY 16, 2023

Nearly 40 million people in the United States suffer from migraine, with the World Health Organization classifying migraine as 1 of the 10 most disabling medical illnesses.

201

201

STAT

FEBRUARY 1, 2023

A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that disruptive innovation in science has dramatically and mysteriously declined 90% since 1945. The study has prompted a wave of news coverage and tweets decrying the apparent languishing of modern science. We feel that the authors make interesting observations on publishing trends, but their conclusions seem to be quite disconnected from the valuable and transformative innovations that benefit h

145

145

Drug Store News

FEBRUARY 16, 2023

The fudgy oat milk-based frozen dessert bars are available in four flavors — fudge n’ vanilla crunch, double chocolate fudge, fudge n’ caramel crunch and mint n’ fudge chip.

111

111

Pharmaceutical Technology

FEBRUARY 23, 2023

GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme. This collaboration is expected to help expedite the clinical manufacturing of RVM-V001 and future mRNA-based vaccines that target infectious diseases such as Clostriodioides difficile infection (CDI) and R

Vaccines 115

Vaccines Communication 115

Fierce Pharma

FEBRUARY 14, 2023

Pfizer CEO's texts with European Commission chief trigger new NYT lawsuit kdunleavy Tue, 02/14/2023 - 10:29

145

145

Fierce Healthcare

FEBRUARY 24, 2023

Major coalition of health groups aims to combat health misinformation rking Fri, 02/24/2023 - 11:17

145

145

Drug Topics

FEBRUARY 6, 2023

Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.

Vaccines 193

Vaccines 193

STAT

FEBRUARY 16, 2023

Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the leading scientists in the groundbreaking field of genetic editing, had reached out two days prior to discuss a new company he was working on. Since helping to discover CRISPR-Cas9 — often referred to as molecular scissors that can cut into the genome and edit DNA — Zhang has founded at least

139

139

Drug Store News

FEBRUARY 8, 2023

CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.

119

119

The Checkup by Singlecare

FEBRUARY 15, 2023

When someone claims to be allergic to exercise it might sound like a creative excuse to avoid working out. But for some, exercise can trigger a type of itchy skin rash, commonly known as exercise-induced hives (urticaria). It can be alarming to break out in red spots after breaking a sweat. Here’s what to know if it happens to you. What are exercise hives?

Immunization 105

Immunization 105

PharmaVoice

FEBRUARY 13, 2023

Why the recently appointed president of commercial solutions sees near limitless potential to expand Klick’s footprint across the life sciences — and how generative AI is playing a role.

105

105

Fierce Healthcare

FEBRUARY 17, 2023

American Telemedicine Association announced 12 telehealth innovators challenge finalists aburky Fri, 02/17/2023 - 11:45

132

132

Drug Topics

FEBRUARY 7, 2023

According to adjusted analyses, vitamin D reduced the risk of diabetes by 15% with a 3-year absolute risk reduction of 3.3%.

201

201

STAT

FEBRUARY 28, 2023

Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Click on each matchup for a short summary of each school’s pioneering research. Then pick your favorites. Help us crown a champ!

133

133